BIOCRYST PHARMACEUTICALS INC Income Statement
BCRX / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Revenue has declined at a 16.6% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $25.2M | $26.4M | $48.3M | $13.6M | $17.3M | $62.4M | $74.6M |
| Cost of Revenue | $19.1M | $12.3M | $4.5M | $6.4M | $7.2M | $1.6M | $3.7M | - | $1.1M | $2.3M | $1.4M | $1.0K | - | $86.0K | $4.5M |
| SG&A Expense | $348.6M | $266.3M | $214.1M | $159.4M | $118.8M | $67.9M | $37.1M | $29.5M | $13.9M | $11.3M | $13.0M | $7.5M | $6.0M | $11.7M | $10.1M |
| R&D Expense | $166.1M | $174.6M | $216.6M | $253.3M | $208.8M | $123.0M | $107.1M | $84.9M | $67.0M | $61.0M | $72.8M | $51.8M | $41.9M | $83.9M | $73.7M |
| Operating Income | $341.0M | -$2.5M | -$103.7M | -$148.4M | -$177.7M | -$174.8M | -$99.5M | -$94.2M | -$57.4M | -$48.6M | -$39.4M | -$45.8M | -$30.7M | -$34.4M | -$13.7M |
| Interest Expense | - | - | $108.2M | $99.1M | $59.3M | $14.5M | $11.9M | $9.2M | $8.6M | $6.5M | $5.2M | $5.0M | $4.8M | $3.8M | $3.8M |
| Income Tax | $3.5M | $1.9M | $310.0K | $2.7M | $2.3M | $0 | $0 | $0 | $0 | $0 | $0 | $17.3M | $8.6M | - | - |
| Net Income | $263.9M | -$88.9M | -$226.5M | -$247.1M | -$184.1M | -$182.8M | -$108.9M | -$101.3M | -$65.8M | -$55.1M | -$43.0M | -$45.2M | -$30.1M | -$33.9M | -$13.5M |
| EPS (Basic) | $1.26 | -$0.43 | -$1.18 | -$1.33 | -$1.03 | -$1.09 | - | - | - | - | -$0.21 | - | - | - | - |
| EPS (Diluted) | $1.21 | -$0.43 | -$1.18 | -$1.33 | -$1.03 | -$1.09 | - | - | -$0.59 | -$0.68 | -$0.21 | -$0.68 | -$0.55 | -$0.76 | -$0.35 |
| Shares Outstanding | 218.6M | 206.7M | 192.2M | 185.9M | 179.1M | 167.3M | 115.6M | 103.2M | 73.8M | 73.4M | 72.0M | 72.0M | 59.1M | 45.7M | 45.0M |
| Operating Margin | - | - | - | - | - | - | - | - | -228.0% | -184.4% | -81.7% | -336.4% | -177.2% | -55.1% | -18.4% |
| Profit Margin | - | - | - | - | - | - | - | - | -261.2% | -209.2% | -89.1% | -332.1% | -173.7% | -54.3% | -18.0% |